Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: AVTX stock price vs NFG: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at NFG's multiple
Needs NFG P/S.
Implied fair value · at AVTX's multiple
Needs AVTX P/S.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: AVTX FY 2025 (ended Dec 31, 2025) · NFG FY 2025 (ended Sep 30, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
AVALO THERAPEUTICS, INC. · implied price per share
Bear
$1.24
Base
$1.45
Bull
$1.67
NATIONAL FUEL GAS CO · implied price per share
Bear
$50.32
Base
$59.19
Bull
$68.07
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.24x
0.96x
Net debt / EBITDA
Leverage against operating earnings
1.03x
2.96x
Cash and equivalents
Liquid reserves on the balance sheet
$98.34M
$43.17M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
CytomX Therapeutics, Inc.
AVTX vs CTMX
IDEAYA Biosciences, Inc.
AVTX vs IDYA
Ocugen, Inc.
AVTX vs OCGN
CLOVER HEALTH INVESTMENTS, CORP. /DE
AVTX vs CLOV
Citius Pharmaceuticals, Inc.
AVTX vs CTXR
NRG ENERGY, INC.
AVTX vs NRG
SPIRE INC
AVTX vs SR
PUBLIC SERVICE ENTERPRISE GROUP INC
AVTX vs PEG
DTE ENERGY CO
AVTX vs DTE
PG&E Corp
AVTX vs PCG
UGI CORP /PA/
AVTX vs UGI
$20.26M
$2.98B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Live quote
Live quote
